- Cal-Bay International, Inc. (PINKSHEETS: CBYI) Puts Together Big Day of Volume but Share Price Slides
- Pacific Clean Water Technologies, Inc. (OTCQB: PCWT) Attracting Attention but Not All of it is Positive
- Is Axiologix, Inc. (PINKSHEETS: AXLX) Any Closer to Completing Targeted Acquisitions?
- With Financing Secured Will PacWest Equities, Inc. (PINKSHEETS: PWEI) Finally Monetize Solar Line of CIGS Manufacturing Technology?
- What Will the Future Bring for Seven Arts Entertainment Inc. (OTCQB: SAPX)?
OTC Equity Archives
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
Tagsaapl advertising amex apple basic materials biopharmaceutical biotechnology cancer capital goods china cloud computing copper diabetes drilling energy energy stocks exploration facebook fda gas gold gold mining google healthcare investors ipad iphone medical marijuana mining mobile NASDAQ natural gas nyse oil oil and gas otcbb penny stock penny stocks petroleum pharmaceutical Pink Sheets pinksheets silver sprint stocks
OTCEquity is a premier site for updated news and financial information regarding penny stocks and small cap companies. We offer a free newsletter, articles about penny stock trading, otc bulletin board analytical data and original news stories about the penny stock companies you are interested in.
Registration to our newsletter is FREE, Join today by entering your email below!
Tag Archives: cancer
It is getting close to crunch time for A.P. Pharma, Inc. (OTCBB: APPA) as the specialty pharmaceutical company’s FDA assigned Prescription Drug User Fee Act (PDUFA) action date of March 27, 2013 is drawing near and the future of their … Continue reading
Can Inovio Pharmaceuticals, Inc. (AMEX: INO) Realize Potential with Multiple Synthetic Vaccines for Wide Range of Medical Issues?
After starting the month of November strong with a share price that hit 0.7200 Inovio Pharmaceuticals, Inc. (AMEX: INO) hit a snag and slipped as low as 0.4400 but the biotechnology company has been posting some pretty impressive numbers of … Continue reading
BSD Medical Corporation (NASDAQ: BSDM) Reports Significant Sales Spike but is it a Difference Maker?
BSD Medical Corporation (NASDAQ: BSDM) delivered some positive news on Tuesday, announcing that they had seen a 391% increase in sales for their MicroThermX Microwave Ablation System product line for September 2012, as compared to September 2011 with their disposable … Continue reading
For those investors who loaded up on CytoCore, Inc. (OTCBB: CYOE) prior to Thursday’s opening then yesterday must have played out like a dream as the biomolecular diagnostics company engaged in the design, development, and commercialization of cost-effective screening systems … Continue reading
Will it ever end for Cannabis Science Inc. (OTCBB: CBIS)? Can a company that has generated less than $150,000 in earned revenues while racking up an accumulated deficit in excess of $70.5 million during their six-plus years of operation really … Continue reading
Genetic Technologies Ltd. (NASDAQ: GENE) has put together a staggering day of growth on Wednesday as shares have jumped from a Tuesday close of 3.12 up to a high of 4.28 today with trading volume already topping the 2.2 million … Continue reading
Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) Can’t Shake Investor Skepticism Despite Positive Results Tie to Lead Cancer Product
There appears to be no end in sight for the volatility surrounding Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) as shares of the biopharmaceutical company continue experience dramatic shifts in price. Activity on Tuesday has further displayed this volatility as PPHM bounced … Continue reading
Is Northwest Biotherapeutics (OTCQB: NWBO) Finally Catching the Attention of Investors with Advancement of Cancer Therapy?
While shares of Northwest Biotherapeutics (OTCQB: NWBO) haven’t quite reached the same levels they were at a year ago it appears as if investors are encouraged by the recent advancements the biotechnology company has made and trading activity has reflected … Continue reading
Exelixis, Inc. (NASDAQ: EXEL) Remains a Big Risk Big Reward Biotech with Everything Riding on Cancer Drug Cabozantinib
It’s possible that the climb back north may have started for Exelixis, Inc. (NASDAQ: EXEL) as the biotechnology company is now in recovery mode following yesterday’s poor performance. On Wednesday shares of EXEL sank as low as 4.27 as investors … Continue reading
Less than a month ago shares of Pluristem Therapeutics (NASDAQ: PSTI) were trading as low as 2.38 but with news released on Monday that the company’s placenta-derived stem cell therapy had helped restore bone-marrow function in a 54-year-old patient suffering … Continue reading